NADP isocitrate dehydrogenase 2 (isocitrate dehydrogenase [NADP] mitochondrial)
Jump to navigation
Jump to search
Function
- catalyzes reversable conversion of isocitrate to 2-oxoglutarate
- role in intermediary metabolism & energy production
- may tightly associate or interact with pyruvate dehydrogenase complex
isocitrate + NADP+ <--> 2-oxoglutarate + CO2 + NADPH
Cofactor:
- binds 1 Mg+2 or Mn+2 per subunit
Structure
- homodimer
- belongs to the isocitrate & isopropylmalate dehydrogenases family
Compartment
Pharmacology
- IDH2 inhibitor enasidenib (Idhifa) FDA-approved for treatment of refactory acute myeloid leukemia (AML) with IDH2 gene mutation
- apparently IDH2 promotes cell growth of AML myelobasts
- vorasidenib (Servier) inhibits mutant IDH2 investigational treatment of gliomas with IDH2 gene mutation
Laboratory
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/O75874.html
- ↑ FDA News Release. August 1, 2017 FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm569421.htm